Nuformix (LON:NFX) Issues Quarterly Earnings Results

Nuformix (LON:NFX) released its earnings results on Wednesday. The company reported GBX (0.46) (($0.01)) earnings per share for the quarter, Digital Look Earnings reports.

Nuformix Stock Up 5.3 %

Shares of NFX opened at GBX 0.08 ($0.00) on Friday. Nuformix has a 52 week low of GBX 0.04 ($0.00) and a 52 week high of GBX 0.34 ($0.00). The stock has a market capitalization of £647,254.90, a price-to-earnings ratio of -1.63 and a beta of 1.22. The company has a debt-to-equity ratio of 1.17, a quick ratio of 3.35 and a current ratio of 1.12. The stock has a fifty day moving average of GBX 0.06 and a 200-day moving average of GBX 0.10.

About Nuformix

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.